Santhera Pharmaceuticals (Schweiz) Ag

Calculating rank

USPTO Granted Patents = 5

% Expired Patents = 100.0

Trademarks = 4

Forward Citations = 7

Loading Chart...

20 inventors (with patents filed for the assignee):

Thomas Meier (4 out of 5 patents)

Bibiana Bielekova (1 out of 8 patents)

Inge Ott (1 out of 2 patents)

4. Ulrich Abel (1 out of 15 patents)

5. Henry McFarland (1 out of 7 patents)

6. Holger Deppe (1 out of 5 patents)

7. Günther Metz (1 out of 1 patent)

8. Michael Soeberdt (1 out of 1 patent)

9. Sonja Nordhoff (1 out of 1 patent)

10. Barbara Hoffmann-Enger (1 out of 1 patent)

11. Philipp Weyermann (1 out of 1 patent)

12. Hervé Siendt (1 out of 1 patent)

13. Christian Rummey (1 out of 1 patent)

14. Miroslav Terinek (1 out of 1 patent)

15. Marco Henneböhle (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 8293800 - Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis (2012-10-23),

2. 8236818 - Substituted imidazopyridine derivatives as melanocortin-4 receptor antagonists (2012-08-07),

3. 7999002 - Use of N-(dibenz(b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) or a pharmaceutically acceptable addition salt thereof for the prophylaxis and/or treatment of muscular dystrophy (2011-08-16),

4. 7977388 - Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of muscular dystrophies (2011-07-12),

5. 7875648 - N-(dibenz(b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the treatment of congenital muscular dystrophy or myopathy resulting from collagen VI deficiency (2011-01-25),

Company Overview

Santhera Pharmaceuticals is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative treatments for rare neuromuscular and mitochondrial diseases. Their portfolio includes products for Duchenne muscular dystrophy and mitochondrial myopathy, with a commitment to improving the lives of patients with unmet medical needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

5 Patents

#3 in Liestal

#1,709 in Switzerland

Liestal, Switzerland